Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program

Detalhes bibliográficos
Autor(a) principal: Pimentel,Leonardo Halley Carvalho
Data de Publicação: 2014
Outros Autores: Alencar,Francisco José, Rodrigues,Leonardo Raphael Santos, Sousa,Francisca Cléa Florenço de, Teles,João Batista Mendes
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos de neuro-psiquiatria (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2014000100028
Resumo: The objective of this study was to evaluate the effects of botulinum toxin type A (BTX-A) on spastic foot in stroke patients in a rehabilitation program. Method: Hemiparetic stroke patients (n=21) enrolled in a rehabilitation program were divided into two groups. The first group (n=11) received a total of 300UI BTX-A, and the second group (n=10) received 100 UI BTX-A. All patients were assessed at baseline and 2, 4, 8 and 12 weeks after injection for Modified Ashworth Score, time walking 10 meters, and the Functional Independence Measure (mFIM) motor score. Results: The higher-dose group exhibited a significant improvement in spasticity, and both groups showed an improvement in time walking 10 meters and mFIM, with no significant differences between them. Conclusions: Our findings suggest that gains in gait velocity and functional independence were not correlated to BTX-A dose.
id ABNEURO-1_ed701e8bb7d8ed9345aa1902649d732a
oai_identifier_str oai:scielo:S0004-282X2014000100028
network_acronym_str ABNEURO-1
network_name_str Arquivos de neuro-psiquiatria (Online)
repository_id_str
spelling Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation programbotulinum toxin type AstrokespasticityThe objective of this study was to evaluate the effects of botulinum toxin type A (BTX-A) on spastic foot in stroke patients in a rehabilitation program. Method: Hemiparetic stroke patients (n=21) enrolled in a rehabilitation program were divided into two groups. The first group (n=11) received a total of 300UI BTX-A, and the second group (n=10) received 100 UI BTX-A. All patients were assessed at baseline and 2, 4, 8 and 12 weeks after injection for Modified Ashworth Score, time walking 10 meters, and the Functional Independence Measure (mFIM) motor score. Results: The higher-dose group exhibited a significant improvement in spasticity, and both groups showed an improvement in time walking 10 meters and mFIM, with no significant differences between them. Conclusions: Our findings suggest that gains in gait velocity and functional independence were not correlated to BTX-A dose. Academia Brasileira de Neurologia - ABNEURO2014-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2014000100028Arquivos de Neuro-Psiquiatria v.72 n.1 2014reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/0004-282X20130189info:eu-repo/semantics/openAccessPimentel,Leonardo Halley CarvalhoAlencar,Francisco JoséRodrigues,Leonardo Raphael SantosSousa,Francisca Cléa Florenço deTeles,João Batista Mendeseng2014-03-28T00:00:00Zoai:scielo:S0004-282X2014000100028Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2014-03-28T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse
dc.title.none.fl_str_mv Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program
title Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program
spellingShingle Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program
Pimentel,Leonardo Halley Carvalho
botulinum toxin type A
stroke
spasticity
title_short Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program
title_full Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program
title_fullStr Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program
title_full_unstemmed Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program
title_sort Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program
author Pimentel,Leonardo Halley Carvalho
author_facet Pimentel,Leonardo Halley Carvalho
Alencar,Francisco José
Rodrigues,Leonardo Raphael Santos
Sousa,Francisca Cléa Florenço de
Teles,João Batista Mendes
author_role author
author2 Alencar,Francisco José
Rodrigues,Leonardo Raphael Santos
Sousa,Francisca Cléa Florenço de
Teles,João Batista Mendes
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Pimentel,Leonardo Halley Carvalho
Alencar,Francisco José
Rodrigues,Leonardo Raphael Santos
Sousa,Francisca Cléa Florenço de
Teles,João Batista Mendes
dc.subject.por.fl_str_mv botulinum toxin type A
stroke
spasticity
topic botulinum toxin type A
stroke
spasticity
description The objective of this study was to evaluate the effects of botulinum toxin type A (BTX-A) on spastic foot in stroke patients in a rehabilitation program. Method: Hemiparetic stroke patients (n=21) enrolled in a rehabilitation program were divided into two groups. The first group (n=11) received a total of 300UI BTX-A, and the second group (n=10) received 100 UI BTX-A. All patients were assessed at baseline and 2, 4, 8 and 12 weeks after injection for Modified Ashworth Score, time walking 10 meters, and the Functional Independence Measure (mFIM) motor score. Results: The higher-dose group exhibited a significant improvement in spasticity, and both groups showed an improvement in time walking 10 meters and mFIM, with no significant differences between them. Conclusions: Our findings suggest that gains in gait velocity and functional independence were not correlated to BTX-A dose.
publishDate 2014
dc.date.none.fl_str_mv 2014-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2014000100028
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2014000100028
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0004-282X20130189
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
dc.source.none.fl_str_mv Arquivos de Neuro-Psiquiatria v.72 n.1 2014
reponame:Arquivos de neuro-psiquiatria (Online)
instname:Academia Brasileira de Neurologia
instacron:ABNEURO
instname_str Academia Brasileira de Neurologia
instacron_str ABNEURO
institution ABNEURO
reponame_str Arquivos de neuro-psiquiatria (Online)
collection Arquivos de neuro-psiquiatria (Online)
repository.name.fl_str_mv Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia
repository.mail.fl_str_mv ||revista.arquivos@abneuro.org
_version_ 1754212775813447680

Registros relacionados